Bio-identical Hormone & Peptide Specialists

Table of Contents
Cardio Res-Q Assessment from $775

Advanced labs, the Cleveland Heart panel and Dr. Varano’s evaluation:

Menopause and Heart Disease Risk: What Changes and What to Check

Menopause and Heart Disease Risk: What Changes and What to Check

Heart disease risk rises around menopause. In the years on either side of your final period, LDL cholesterol goes up, body fat increases and shifts toward the abdomen, and blood pressure keeps climbing with age. None of this causes symptoms, which is why it is easy to miss.

The useful response is to check your numbers in midlife and act on what you find. Hormone therapy can be very helpful for menopause symptoms, but it is not a treatment for preventing heart disease.

Key takeaways

  • Around menopause, LDL cholesterol rises and body fat increases and shifts toward the abdomen, all without symptoms.
  • A cholesterol result from before the transition may be out of date, so it is worth repeating.
  • Blood pressure and blood sugar also climb in midlife, though this tracks aging more than menopause itself.
  • Menopause before 40 counts as a factor that raises estimated heart risk, so tell your clinician.
  • Hormone therapy can help menopause symptoms but is not recommended for preventing heart disease.

Why heart risk rises around menopause

Women on average develop coronary heart disease several years later than men, and their risk increases notably after menopause. For a long time it was unclear whether this was due to menopause itself or simply to getting older.

Studies that followed the same women through the transition have helped separate the two. In a 2020 scientific statement, the American Heart Association reviewed that research and described the menopause transition as a time of accelerating cardiovascular risk, with adverse changes in body composition, cholesterol and measures of blood vessel health.1

The statement calls midlife a critical window for early prevention. That is the practical message: these are the years when a check is most informative.

Cholesterol: the clearest change

The best evidence comes from SWAN, the Study of Women's Health Across the Nation, which examined women every year through menopause. Among 1,054 women who reached natural menopause without using hormone therapy beforehand, total cholesterol, LDL cholesterol and apolipoprotein B all rose substantially within the year before and after the final menstrual period.2

The pattern was similar across ethnic groups, and it matched the timing of menopause and not simply age. The researchers concluded that women have a distinct rise in lipids at this point and that monitoring cholesterol in perimenopause should help prevention.

So a cholesterol result from your early 40s may no longer describe you at 52. If your last panel was before the transition, it is worth repeating. Apolipoprotein B, or ApoB, reflects the number of plaque-forming particles, and our guide to the ApoB test explains when it adds information.

Blood pressure and blood sugar

Blood pressure, glucose and insulin also drift upward in midlife. In SWAN, however, these followed a steady line that fit chronological aging, with no extra jump at the final period.2

That distinction does not make them less important. High blood pressure is one of the strongest drivers of heart attack and stroke in women, and it has no symptoms. Whatever the cause, midlife is when it often first crosses into a range that needs attention. Rising blood sugar and insulin resistance deserve the same watchfulness.

Body fat: where it goes matters

Many women notice their shape changing even when their weight does not move much. SWAN measured this with body scans. At the start of the menopause transition the rate of fat gain doubled and lean mass began to fall, and both trends continued until about two years after the final period.3

Body weight itself rose steadily through the premenopausal years and did not speed up at the transition. In other words, the scale can stay fairly steady while your body composition shifts underneath it.

The American Heart Association statement also describes a move toward fat stored around the abdominal organs, known as visceral fat, which is the kind most closely tied to heart and metabolic risk.1 A waist measurement tells you more about this than weight alone.

Early and premature menopause

Menopause before age 40 is called premature menopause. It can happen naturally or after surgery to remove both ovaries. US cholesterol guidelines count a history of menopause before 40 as a factor that raises a woman's estimated heart risk.

A study of 144,260 postmenopausal women in the UK put numbers on this. After adjusting for standard risk factors and hormone therapy use, natural premature menopause was linked to a 36% higher risk of a group of cardiovascular diseases, and surgical premature menopause to an 87% higher risk. The authors described the increase as small but statistically significant.4

If your periods stopped before 40, or before 45, tell any clinician who is assessing your heart risk. It is a detail that often goes unasked.

Hormone therapy is not a heart prevention treatment

This point is often blurred, so it is worth stating plainly. Hormone therapy is not recommended for the purpose of preventing heart disease.56

The US Preventive Services Task Force recommends against using hormone therapy for the primary prevention of chronic conditions in postmenopausal women.6 The Menopause Society's 2022 position statement describes hormone therapy as the most effective treatment for hot flashes and night sweats, and says the balance of benefit and risk is favorable for treating bothersome symptoms in women who are under 60 or within 10 years of menopause and have no contraindications.

The same statement says the balance appears less favorable for women who start more than 10 years after menopause or after age 60, because of greater absolute risks of coronary heart disease, stroke, blood clots and dementia.5

The decision about hormone therapy belongs with your symptoms, your history and your own clinician. Your heart risk is managed separately, through blood pressure, cholesterol, blood sugar, activity, food and not smoking.

What to check in midlife

CheckWhy now
Lipid panel, repeated after the transitionLDL cholesterol and ApoB rise around the final period
Blood pressure, including home readingsClimbs with age and causes no symptoms
Fasting glucose and A1cBlood sugar drifts upward in midlife
Waist measurementFat gain speeds up even when weight does not
Your age at menopause, shared with your doctorMenopause before 40 raises estimated risk

Your next step

If you are in perimenopause or past menopause and have not had your heart risk looked at since, start with the basics above. Our guide to a heart disease risk assessment explains what a fuller preventive evaluation covers.

You can also answer the three quick questions in the screener on the Cardio Res-Q program page. Perimenopause and menopause are among the risk factors it asks about.

Cardiovascular Risk Screener

Are You a Candidate for Cardio Res-Q?

Three quick questions about the risk factors we screen for. Your answers stay between you and the clinic.

Frequently asked questions

Does menopause cause heart disease?

Not directly. Menopause brings changes that raise risk, most clearly a rise in LDL cholesterol and a shift in body fat, and these add to the effects of aging. Heart disease still depends on the full set of risk factors, most of which can be measured and managed.

Why did my cholesterol go up when nothing else changed?

This is common. In a large study that tracked women through menopause, total cholesterol, LDL cholesterol and ApoB rose within the year before and after the final period, independent of aging alone. It is a reason to recheck your numbers and discuss them with your clinician, not a sign you did something wrong.

Should I take hormone therapy to protect my heart?

No. Hormone therapy is not recommended for preventing heart disease, and the US Preventive Services Task Force recommends against using it to prevent chronic conditions. It is prescribed for menopause symptoms, and whether it suits you is a separate conversation with your clinician.

I went through menopause before 40. What should I do?

Tell your doctor, because US guidelines treat menopause before 40 as a factor that raises estimated heart risk. It does not mean you will develop heart disease. It means your blood pressure, cholesterol and blood sugar deserve earlier and closer attention.

Related reading

This article is for general education and is not medical advice. Decisions about testing and medication should be made with your clinician. If you have chest pain or other symptoms of a heart attack, call 911.

Optimize Your Health Today!

Cardio Res-Q starts with the $775 Comprehensive or $999 Enhanced Assessment, led by Dr. Varano.

age management doctor philadelphia
Send Us A Message
About Dr. Kenneth Varano, D.O.
age management doctor philadelphia

YoungerMeMD is a physician-led practice in Anti-Aging, Functional and Preventive Medicine, and your care is delivered by our whole clinical team. That team works under Medical Director Kenneth Varano, D.O., who brings over 30 years in clinical medicine and more than 20 years in age management and functional medicine — using science-backed, patient-focused strategies that restore balance, vitality, and health longevity.

About Barbara Dougherty
anti aging treatments

Barbara Dougherty, MSN, CRNP, is a Board-Certified Family Nurse Practitioner and Certified Menopause Practitioner (MSCP) specializing in optimizing hormones, and improving cardio-metabolic health. 

Read Our Reviews

“I’ve been seeing Dr. Varano for just over a year now, and I don’t think I’ve been this healthy and energetic since grade school.

Transform Your Health Today

Ready to take the first step toward renewed energy, balance, and longevity? New patients can register for an initial evaluation to begin their personalized anti-aging journey with YoungerMe MD. Live Younger. Better. Longer. — with YoungerMe MD.

References

  1. El Khoudary SR, et al. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. Circulation 2020. PMID 33251828 · doi:10.1161/CIR.0000000000000912↩
  2. Matthews KA, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?. J Am Coll Cardiol 2009. PMID 20082925 · doi:10.1016/j.jacc.2009.10.009↩
  3. Greendale GA, et al. Changes in body composition and weight during the menopause transition. JCI Insight 2019. PMID 30843880 · doi:10.1172/jci.insight.124865↩
  4. Honigberg MC, et al. Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease. JAMA 2019. PMID 31738818 · doi:10.1001/jama.2019.19191↩
  5. The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 2022. PMID 35797481 · doi:10.1097/GME.0000000000002028↩
  6. US Preventive Services Task Force; Mangione CM, et al. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement. JAMA 2022. PMID 36318127 · doi:10.1001/jama.2022.18625↩
Book a Discovery Call Peptide Consult
Close
Book a Discovery Call
Close
Peptide Consult







    Transform Your
    Health & Wellness

    Fill up the form below to get started

      Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.

      Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.

      DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.

      Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.

      Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.

      Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.

      Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.

      Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.

      What It Evaluates

      Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:

      Conditions We Identify